Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 384-390 , September 2006

Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: A review of the H. Lee Moffitt Cancer Center experience

Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Atlanta, GA, October 3–7, 2004.

  • Javier F. Torres-Roca, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-813-972-8424; fax: +1-813-979-7231.
  • ,
  • Alan B. Cantor, Ph.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Sonia Shukla

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Michael E. Montejo, B.S.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Jay Friedland, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • John D. Seigne, M.B.

      Affiliations

    • Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
  • ,
  • Randy Heysek, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Julio Pow-Sang, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA

Received 27 June 2005 ,Revised 16 December 2005 ,Accepted 22 December 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.F.T.-R. is supported by a K08 CA108926-01 award from the NCI.

PII: S1078-1439(06)00007-X

doi: 10.1016/j.urolonc.2005.12.003

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 384-390 , September 2006